RaySearch Laboratories AB Statistics
RaySearch Laboratories AB (27R) Stock Statistics & Valuation Metrics
Total Valuation
RaySearch Laboratories AB has a market cap or net worth of EUR 551.66M. The enterprise value is EUR 6.49B.
- Market Cap
- EUR 551.66M
- Enterprise Value
- EUR 6.49B
Share Statistics
RaySearch Laboratories AB has 30,799,536 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 30,799,536
- Owned by Insiders
- ―
- Owned by Institutions
- 7.16%
Financial Efficiency
RaySearch Laboratories AB’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 16.99%.
- Return on Equity (ROE)
- 0.23
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 16.99%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- 2.90M
- Profits Per Employee
- 490.95K
- Employee Count
- 464
- Asset Turnover
- 0.67
- Inventory Turnover
- 17.86
Valuation Ratios
The current PE Ratio of RaySearch Laboratories AB is 29.70. RaySearch Laboratories AB’s PEG ratio is -5.00.
- PE Ratio
- 29.70
- PS Ratio
- 4.47
- PB Ratio
- 7.41
- Price to FCF
- 14.82
- Price to Operating Cash Flow
- 14.04
- PEG Ratio
- -5.00
Income Statement
In the last 12 months, RaySearch Laboratories AB had revenue of 1.34B and earned 227.80M in profits. Earnings per share was 6.65.
- Revenue
- 1.34B
- Gross Profit
- 951.40M
- Operating Income
- 321.80M
- Pretax Income
- 287.80M
- Net Income
- 227.80M
- EBITDA
- 612.80M
- Earnings Per Share (EPS)
- 6.65
Cash Flow
In the last 12 months, operating cash flow was 424.90M and capital expenditures -23.20M, giving a free cash flow of 401.70M billion.
- Operating Cash Flow
- 424.90M
- Free Cash Flow
- 401.70M
- Free Cash Flow per Share
- 12.04
Dividends & Yields
RaySearch Laboratories AB pays an annual dividend of ―, resulting in a dividend yield of 1.84%
- Dividend Per Share
- ―
- Dividend Yield
- 1.84%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.75%
- Earnings Yield
- 3.43%
Stock Price Statistics
- Beta
- 1.14
- 52-Week Price Change
- -21.86%
- 50-Day Moving Average
- 16.15
- 200-Day Moving Average
- 17.33
- Relative Strength Index (RSI)
- 46.70
- Average Volume (3m)
- 307
Important Dates
RaySearch Laboratories AB upcoming earnings date is Feb 10, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 10, 2027
- Ex-Dividend Date
- ―
Financial Position
RaySearch Laboratories AB as a current ratio of 1.70, with Debt / Equity ratio of 40.07%
- Current Ratio
- 1.70
- Quick Ratio
- 1.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.02
- Interest Coverage Ratio
- 41.26
Taxes
In the past 12 months, RaySearch Laboratories AB has paid 60.00M in taxes.
- Income Tax
- 60.00M
- Effective Tax Rate
- 0.21
Enterprise Valuation
RaySearch Laboratories AB EV to EBITDA ratio is 11.37, with an EV/FCF ratio of 15.43.
- EV to Sales
- 4.65
- EV to EBITDA
- 11.37
- EV to Free Cash Flow
- 15.43
- EV to Operating Cash Flow
- 14.59
Balance Sheet
RaySearch Laboratories AB has EUR 158.30M in cash and marketable securities with EUR 406.00M in debt, giving a net cash position of -EUR 247.70M billion.
- Cash & Marketable Securities
- EUR 158.30M
- Total Debt
- EUR 406.00M
- Net Cash
- -EUR 247.70M
- Net Cash Per Share
- -EUR 8.04
- Tangible Book Value Per Share
- EUR 6.55
Margins
Gross margin is 67.79%, with operating margin of 19.15%, and net profit margin of 15.36%.
- Gross Margin
- 67.79%
- Operating Margin
- 19.15%
- Pretax Margin
- 19.77%
- Net Profit Margin
- 15.36%
- EBITDA Margin
- 40.91%
- EBIT Margin
- 19.15%
Analyst Forecast
The average price target for RaySearch Laboratories AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.78%
- EPS Growth Forecast
- -3.18%

